Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Lifecell International Pvt. |
RCV000012577 | SCV003914724 | pathogenic | Dent disease type 1 | criteria provided, single submitter | clinical testing | A Hemizygote, Splice site donor variant c.1347+1G>T in Exon 8 of the CLCN5 gene that results in the amino acid substitution was identified. The observed variant is novel in gnomAD exomes. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic (Variant ID: 18451). This variant has been previous reported in association with Dent disease by Tosetto E et al., 2009. Based on the above evidence this variant has been classified as Pathogenic according to the ACMG guidelines. | |
OMIM | RCV000012577 | SCV000032811 | pathogenic | Dent disease type 1 | 2009-10-01 | no assertion criteria provided | literature only |